NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central ...

Pharmaceutics is the scientific discipline concerned with the process of creating the dosage form (such as a pill for oral administration or a powder for intravenous injection) of a therapeutic ...

缺血性中风（IS, ischemic stroke）依然是全球范围内导致人类死亡和长期残疾的主要原因之一。尽管早期干预措施如组织型纤溶酶原激活剂给药和机械祛栓（mechanical ...

Pharmaceutics is a multidisciplinary science that focuses on the study of the physical, chemical and biological properties of drugs and dosage forms. Cutting across the traditional disciplinary ...

Molecular Pharmaceutics is excited to announce a Call for Papers for a special issue titled “Advances in Pharmaceutical Research in India”. Researchers from academia, industry and research institutes ...

After hours: January 24 at 6:36:53 p.m. EST ...

NLS Pharmaceutics AG (NLSP) stock has hit a 52-week low, trading at $1.73, with a market capitalization of just $2.94 million ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

NLS Pharmaceutics (NLSP) and Kadimastem announced that Kadimastem has issued a notice to convene a special general meeting of Kadimastem’s ...

30, 2024 /PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for ...